Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 2/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | FDPS | P14324 | 1/20 | 0.30 |
| ▸ | CTSK | P43235 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6705279 | 0.93 | OPRM1 (0.42) | DNM1LMNAOPRM1CA1 | |
| SCHEMBL6032548 | 0.91 | OPRM1 (0.41) | DNM1LMNAOPRM1TSHR | |
| SCHEMBL6703074 | 0.84 | — | — | |
| SCHEMBL14779512 | 0.74 | DNM1 (0.38) | DNM1LMNAOPRM1ALDH1A1TDP1 | |
| SCHEMBL15299174 | 0.74 | DNM1 (0.38) | DNM1LMNAOPRM1ALDH1A1TDP1 | |
| SCHEMBL28755384 | 0.73 | — | — | |
| SCHEMBL14747631 | 0.72 | DNM1 (0.36) | DNM1LMNAOPRM1ALDH1A1TDP1 | |
| SCHEMBL22534495 | 0.72 | — | — | |
| SCHEMBL28770178 | 0.72 | — | — | |
| SCHEMBL28024615 | 0.72 | ALDH1A1 (0.37) | DNM1LMNAOPRM1ALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040076593-A1 | Composition containing a modified nitrocellulose | L'OREAL (FR) | 2004-04-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040076593-A1 | Composition containing a modified nitrocellulose | VCL, C9, LPO | DNM1 3809/4885LMNA 660/4885OPRM1 1477/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.